Aster DM Healthcare Latest Share Price (ASTERDM)
TODAY IN ONE LINE
ASTERDM is little changed at ₹844.45 on above-average volume (2.2x avg) — a quiet consolidation day, supported by recent strong earnings.
With a market cap of ₹73,442.76 Cr., it trades at a P/E of 113.48. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Aster DM Healthcare flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 71.5% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 18.2% and Profit up 42.0%
- ●Healthy Operating MarginsOPM is structurally strong at 18.6%
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Expensive ValuationTrading at a high P/E ratio of 103.7x
- ●Rising Receivables vs SalesReceivables grew 35.7% outpacing sales growth of 11.9%
Latest Aster DM Healthcare News
What changed recently?
Recent events, corporate actions, and announcements.
Aster DM Healthcare Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Aster DM Healthcare Limited, framed against the sector median so the premium or discount is obvious at a glance.
Aster DM Healthcare Limited trades at a P/E of 113.48× and P/B of 9.62×, against the Healthcare sector median P/E of 46.27×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Aster DM Healthcare Limited technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Aster DM Healthcare Limited — derived from the latest tape, not yesterday's close.
Aster DM Healthcare Limited last traded at ₹844.45 with an intraday range of ₹809.6–₹874 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹844.45| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1004.57 | +160.12 | +18.96% |
| R3 | 940.17 | +95.72 | +11.33% |
| R2 | 907.08 | +62.63 | +7.42% |
| R1 | 875.77 | +31.32 | +3.71% |
| PIVOT | 842.68 | -1.77 | -0.21% |
| CURRENT | 844.45 | — | — |
| S1 | 811.37 | -33.08 | -3.92% |
| S2 | 778.28 | -66.17 | -7.84% |
| S3 | 746.97 | -97.48 | -11.54% |
| S4 | 682.57 | -161.88 | -19.17% |
ASTERDM is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹809.6–₹825.4
Trading Inside opening range
Aster DM Healthcare Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Aster DM Healthcare Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Aster DM Healthcare Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹73,442.76 Cr. and reported EPS of ₹7.51.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 4,138 | 4,643 ▲ 12.2% |
| Sales Growth YoY %Derived | 11.88% | 12.20% |
| Other Income | 148 | 126 ▼ 15.3% |
| Total Income | 4,287 | 4,769 ▲ 11.2% |
| 938 | 1,049 ▲ 11.8% | |
| Gross ProfitDerived | 3,200 | 3,594 ▲ 12.3% |
| Gross Margin %Derived | 77.33% | 77.41% |
| 2,436 | 2,693 ▲ 10.6% | |
| EBITDA (Operating Profit)Derived | 765 | 901 ▲ 17.9% |
| OPM %Derived | 18.47% | 19.41% |
| 323 | 355 ▲ 9.9% | |
| Profit Before Tax (PBT) | 490 | 607 ▲ 23.8% |
| 134 | 143 ▲ 6.1% | |
| Effective Tax %Derived | 27.42% | 23.50% |
| Profit/Loss from Discontinued Ops | 5,071 | — ▼ 100.0% |
| Total Profit for Period | 5,408 | 427 ▼ 92.1% |
| Less: Non-controlling Interests | 30 | 39 ▲ 29.6% |
| Net Profit (Owner's PAT)Derived | 5,378 | 388 ▼ 92.8% |
| Net Profit Margin %Derived | 129.95% | 8.36% |
| PAT Growth YoY %Derived | 4,059.83% | -92.78% |
| Earnings Per Share (EPS ₹) | 107.66 | 7.49 ▼ 93.0% |
| Diluted Shares Outstanding (Cr) | 50 | 52 ▲ 3.7% |
| Share of Profit from Associates/JVs | -19 | -37 ▼ 95.7% |
| Other Comprehensive Income (Net of Tax) | -2 | 0 ▲ 117.1% |
| Total Expenses (incl. D&A & Interest) | 3,797 | 4,162 ▲ 9.6% |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | 18.37% | 18.27% |
| Other Cost % of RevenueDerived | 40.48% | 39.74% |
| Interest Coverage (x)Derived | 4.17x | 5.18x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 6,721 | 7,963 ▲ 18.5% | 8,739 ▲ 9.7% | 8,608 ▼ 1.5% | 10,253 ▲ 19.1% | 11,933 ▲ 16.4% | 3,699 ▼ 69.0% | 4,138 ▲ 11.9% | 4,643 ▲ 12.2% | |
| Sales Growth YoY %Derived | — | 18.47% | 9.74% | -1.49% | 19.11% | 16.38% | -69.00% | 11.88% | 12.20% | |
| Other Income | 45 | 35 ▼ 23.8% | 38 ▲ 9.4% | 50 ▲ 32.0% | 51 ▲ 1.4% | 78 ▲ 54.5% | 25 ▼ 68.2% | 148 ▲ 496.5% | 126 ▼ 15.3% | |
| Total Income | 6,767 | 7,997 ▲ 18.2% | 8,776 ▲ 9.7% | 8,658 ▼ 1.3% | 10,304 ▲ 19.0% | 12,011 ▲ 16.6% | 3,724 ▼ 69.0% | 4,287 ▲ 15.1% | 4,769 ▲ 11.2% | |
2,059 | 2,420 ▲ 17.5% | 2,635 ▲ 8.9% | 2,549 ▼ 3.3% | 2,892 ▲ 13.5% | 3,532 ▲ 22.1% | 916 ▼ 74.1% | 938 ▲ 2.5% | 1,049 ▲ 11.8% | ||
| Gross ProfitDerived | 4,662 | 5,543 ▲ 18.9% | 6,103 ▲ 10.1% | 6,060 ▼ 0.7% | 7,362 ▲ 21.5% | 8,401 ▲ 14.1% | 2,783 ▼ 66.9% | 3,200 ▲ 15.0% | 3,594 ▲ 12.3% | |
| Gross Margin %Derived | 69.37% | 69.61% | 69.84% | 70.39% | 71.80% | 70.40% | 75.24% | 77.33% | 77.41% | |
4,049 | 4,680 ▲ 15.6% | 4,845 ▲ 3.5% | 4,997 ▲ 3.1% | 5,878 ▲ 17.6% | 6,836 ▲ 16.3% | 2,205 ▼ 67.7% | 2,436 ▲ 10.5% | 2,693 ▲ 10.6% | ||
| EBITDA (Operating Profit)Derived | 613 | 863 ▲ 40.8% | 1,258 ▲ 45.7% | 1,063 ▼ 15.5% | 1,483 ▲ 39.6% | 1,565 ▲ 5.5% | 578 ▼ 63.1% | 765 ▲ 32.3% | 901 ▲ 17.9% | |
| OPM %Derived | 9.12% | 10.84% | 14.39% | 12.35% | 14.47% | 13.12% | 15.62% | 18.47% | 19.41% | |
612 | 484 ▼ 20.9% | 926 ▲ 91.3% | 911 ▼ 1.6% | 898 ▼ 1.5% | 1,110 ▲ 23.6% | 330 ▼ 70.2% | 323 ▼ 2.3% | 355 ▲ 9.9% | ||
| Profit Before Tax (PBT) | 305 | 411 ▲ 34.4% | 330 ▼ 19.6% | 202 ▼ 39.0% | 636 ▲ 215.7% | 534 ▼ 16.1% | 273 ▼ 49.0% | 490 ▲ 79.8% | 607 ▲ 23.8% | |
26 | 43 ▲ 64.6% | 15 ▼ 64.2% | 27 ▲ 77.0% | 36 ▲ 31.5% | 60 ▲ 66.5% | 57 ▼ 5.2% | 134 ▲ 137.8% | 143 ▲ 6.1% | ||
| Effective Tax %Derived | 8.54% | 10.46% | 4.66% | 13.51% | 5.63% | 11.16% | 20.74% | 27.42% | 23.50% | |
| Profit/Loss from Discontinued Ops | — | — | — | — | — | — | 7 | 5,071 ▲ 73609.3% | — ▼ 100.0% | |
| Total Profit for Period | 282 | 367 ▲ 30.4% | 315 ▼ 14.3% | 178 ▼ 43.5% | 601 ▲ 238.0% | 475 ▼ 20.9% | 212 ▼ 55.5% | 5,408 ▲ 2456.2% | 427 ▼ 92.1% | |
| Less: Non-controlling Interests | 13 | 34 ▲ 167.1% | 38 ▲ 11.3% | 30 ▼ 20.9% | 75 ▲ 149.5% | 51 ▼ 32.6% | 82 ▲ 62.7% | 30 ▼ 63.5% | 39 ▲ 29.6% | |
| Net Profit (Owner's PAT)Derived | 269 | 333 ▲ 23.9% | 277 ▼ 17.0% | 148 ▼ 46.6% | 526 ▲ 256.0% | 425 ▼ 19.2% | 129 ▼ 69.6% | 5,378 ▲ 4059.8% | 388 ▼ 92.8% | |
| Net Profit Margin %Derived | 4.00% | 4.18% | 3.17% | 1.72% | 5.13% | 3.56% | 3.50% | 129.95% | 8.36% | |
| PAT Growth YoY %Derived | — | 23.89% | -16.96% | -46.59% | 256.02% | -19.22% | -69.57% | 4,059.83% | -92.78% | |
| Earnings Per Share (EPS ₹) | 5.32 | 6.59 ▲ 23.9% | 5.54 ▼ 15.9% | 2.96 ▼ 46.6% | 10.53 ▲ 255.7% | 8.51 ▼ 19.2% | 2.59 ▼ 69.6% | 107.66 ▲ 4056.8% | 7.49 ▼ 93.0% | |
| Diluted Shares Outstanding (Cr) | 51 | 51 ▲ 0.0% | 50 ▼ 1.1% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 50 ▲ 0.0% | 52 ▲ 3.7% | |
| Share of Profit from Associates/JVs | 2 | -0 ▼ 110.9% | -0 ▲ 24.0% | 4 ▲ 1952.6% | 1 ▼ 84.7% | 1 ▲ 125.9% | -11 ▼ 1029.5% | -19 ▼ 66.8% | -37 ▼ 95.7% | |
| Other Comprehensive Income (Net of Tax) | 10 | 62 ▲ 500.7% | 145 ▲ 131.7% | -50 ▼ 134.4% | 93 ▲ 288.0% | 199 ▲ 112.9% | 46 ▼ 76.7% | -2 ▼ 104.5% | 0 ▲ 117.1% | |
| Total Expenses (incl. D&A & Interest) | 6,461 | 7,587 ▲ 17.4% | 8,446 ▲ 11.3% | 8,457 ▲ 0.1% | 9,668 ▲ 14.3% | 11,477 ▲ 18.7% | 3,451 ▼ 69.9% | 3,797 ▲ 10.0% | 4,162 ▲ 9.6% | |
| Material Cost % of RevenueDerived | — | — | — | — | — | — | — | — | — | |
| Employee Cost % of RevenueDerived | 33.79% | 33.76% | 33.23% | 32.01% | 31.84% | 33.23% | 18.27% | 18.37% | 18.27% | |
| Other Cost % of RevenueDerived | 26.46% | 25.01% | 22.22% | 26.04% | 25.49% | 24.06% | 41.34% | 40.48% | 39.74% | |
| Interest Coverage (x)Derived | 1.71x | 3.11x | 1.87x | 1.52x | 3.28x | 2.38x | 3.25x | 4.17x | 5.18x |
Aster DM Healthcare segment analysis : revenue and profit mix.
Disclosed business segments at Aster DM Healthcare with their share of revenue and profit, switchable between consolidated and standalone reporting.
Aster DM Healthcare discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Aster DM Healthcare Limited.
Our AI distills the core fundamental drivers supporting Aster DM Healthcare Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Aster DM Healthcare Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Latest quarterly EPS grew 77.4% YoY, demonstrating robust earnings acceleration.
TTM revenue growth 18.2% outpaces peer average, signaling strong market traction.
Operating margin 12.91% supports healthy profitability across segments.
Low debt-to-equity 0.0049 and positive operating cash flow ensure financial stability.
Diversified business model spanning hospitals, clinics, pharmacies, optical outlets reduces concentration risk.
Key Risks.
P/E ratio 103.69 signals significant overvaluation relative to earnings and peer multiples.
5-year revenue growth 0% indicates stagnant long-term expansion despite recent momentum.
Net margin 6.45% lags peer leaders, reflecting weak cost control and operational efficiency.
ROE 10.70% and ROCE 11.40% fall below peer averages, signaling suboptimal capital deployment.
FII holdings eased from 23.90% to 19.16%, signals foreign investor caution and ownership risk.
Flip Conditions.
Valuation risk. a P/E above 148 (~3.2× the sector multiple of 46.3) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Aster DM Healthcare Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Aster DM Healthcare Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Aster DM Healthcare Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Aster DM Healthcare Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Aster DM Healthcare Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Aster DM Healthcare Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Aster DM Healthcare Limited stood at 38.3% of traded volume, against a 20-day average of 57.0%.
Aster DM Healthcare announcements: results, concalls, ratings, M&A.
Filings Aster DM Healthcare sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Aster DM Healthcare files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 191 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Aster DM Quality Care Limited has informed the Exchange about schedule of Analyst/Investors call for quarter ended 30 June 2026
Credit Rating
Aster DM Quality Care Limited has informed the Exchange about Credit Rating
Name Change
ASTERDM: Members of the Exchange are hereby informed that the name of Aster DM Healthcare Limited will be changed to Aster DM Quality Care Limited…
General Updates
Aster DM Healthcare Limited has informed the Exchange about allotment of equity shares to the shareholders of transferor Company (QCIL) pursuant to…
Credit Rating- Revision
Aster DM Healthcare Limited has informed the Exchange about Credit Rating- Revision
Investor decks & rating reports.
Aster DM Healthcare dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Aster DM Healthcare has declared, sequenced by announce and record date.
Aster DM Healthcare corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
Aster DM Healthcare insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Aster DM Healthcare as reported to SEBI — buying and selling signals from the people who know the business best.
Aster DM Healthcare insider activity below tracks 5 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Union (Mauritius) Holdings Limited | Insider | 20 Mar 2025 | buy | +2.00 Cr | ₹865.16 Cr. | ₹433.00 |
| Union Investments Private Limited | Insider | 20 Mar 2025 | buy | +2.00 Cr | ₹865.16 Cr. | ₹433.00 |
| Union Investments Private Limited | Insider | 07 Mar 2025 | buy | +8.51 Cr | ₹3,552.37 Cr. | ₹417.45 |
| Union Investments Private Limited | Insider | 04 Mar 2025 | buy | +18.69 Cr | ₹7,362.04 Cr. | ₹394.00 |
| Union (Mauritius) Holdings Limited | Insider | 04 Mar 2025 | buy | +2.00 Cr | ₹787.23 Cr. | ₹394.00 |
About Aster DM Healthcare Limited: business, sector, key facts.
What Aster DM Healthcare Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Aster DM Healthcare Limited operates in the Hospital industry under the Healthcare sector, listed as NSE: ASTERDM, BSE: 540975.
Aster DM Healthcare Limited is a prominent healthcare provider operating across a wide geographical expanse. Its services span several countries in the Middle East and South Asia, including India, the United Arab Emirates, Qatar, Oman, Saudi Arabia, Jordan, Kuwait, Bahrain, and Mauritius. This extensive reach establishes Aster DM as a significant player in the international healthcare market, delivering services to a diverse patient population.
The company's business is structured around four key segments: Hospitals, Clinics, Retail Pharmacies, and Others. The Hospitals segment encompasses the operation of large-scale hospitals, often including integrated in-house pharmacies to provide comprehensive patient care within a single facility. Similarly, the Clinics segment focuses on smaller-scale clinics, also frequently with integrated pharmacies for convenient access to medications.
Aster DM's Retail Pharmacies segment represents a substantial portion of its business. This encompasses a network of both physical retail pharmacies and online pharmacy services, extending access to medications and healthcare products beyond the company's hospital and clinic settings. The addition of optical outlets further diversifies this segment, offering comprehensive eye care and related products to a wider customer base.
The "Others" segment encompasses a variety of supporting services and business activities. This includes healthcare consultancy, offering specialized advice and expertise to other healthcare organizations or institutions, as well as other ancillary services that support the core operations of the company’s hospital, clinic, and retail pharmacy networks. This diversified approach allows Aster DM to expand its revenue streams and offers opportunities for growth and strategic partnerships.
In summary, Aster DM Healthcare Limited's business model centers around providing a comprehensive range of healthcare services, from hospital-based care to retail pharmacy access, across multiple countries. Its diversified business structure, coupled with its international reach, positions the company for continued growth and influence in the global healthcare landscape. The company's long history, beginning in 1987, demonstrates its enduring commitment to delivering quality healthcare services and its ability to adapt and expand within a dynamic market.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwal's Health Care (AGARWALEYE) Share PricePeer
- Apollo Hospitals Enterprise (APOLLOHOSP) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- GPT Healthcare (GPTHEALTH) Share PricePeer
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Other overvalued NSE stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Aster DM Healthcare Limited (ASTERDM).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Aster DM Healthcare Limited (ASTERDM)?
The current share price of Aster DM Healthcare Limited (ASTERDM) is ₹844.45. Today, the stock has gained by ₹2.35 (0.28%), trading in a range of ₹809.60 to ₹874.00. The stock opened at ₹823.90 with a trading volume of 24,38,796 shares.
02Is Aster DM Healthcare Limited stock a good investment for long-term?
Aster DM Healthcare Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹73,442.76 Cr., P/E ratio of 113.48, ROE of 10.7%, and ROCE of 11.4%. The dividend yield stands at 0.48%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Aster DM Healthcare Limited stock?
The 52-week high price of Aster DM Healthcare Limited (ASTERDM) is ₹856.75, while the 52-week low is ₹519.10. Currently trading at ₹844.45, the stock is 62.68% above its 52-week low and 1.44% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Aster DM Healthcare Limited stock at the current price?
Whether to buy Aster DM Healthcare Limited stock at ₹844.45 depends on multiple factors. The stock is currently trading with a P/E ratio of 113.48 and P/B ratio of 9.62. Today's performance shows a gain of 0.28%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Aster DM Healthcare Limited and when is the next dividend?
Aster DM Healthcare Limited offers a dividend yield of 0.48%, which means for every ₹100 invested at the current price of ₹844.45, you can expect to receive approximately ₹0.48 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Aster DM Healthcare Limited?
Aster DM Healthcare Limited's key financial metrics include: P/E Ratio: 113.48, P/B Ratio: 9.62, ROE: 10.7%, ROCE: 11.4%, Dividend Yield: 0.48%, EPS: ₹7.51, Book Value: ₹88.80, and Debt-to-Equity: 0.49. The company's market cap stands at ₹73,442.76 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Aster DM Healthcare Limited stock performing today in the market?
Aster DM Healthcare Limited stock opened at ₹823.90 and is currently trading at ₹844.45, showing a gain of ₹2.35 (0.28%). The intraday high is ₹874.00 and low is ₹809.60. The trading volume stands at 24,38,796 shares, indicating strong market participation today.
08What is the P/E ratio of Aster DM Healthcare Limited and what does it indicate?
Aster DM Healthcare Limited has a Price-to-Earnings (P/E) ratio of 113.48, which means investors are willing to pay 113.48 for every ₹1 of earnings. With an EPS of ₹7.51, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Aster DM Healthcare Limited (ASTERDM) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.